SRS Capital Advisors »

Avita Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $35 10 3.50
2025-09-30 $2.3k 441 5.11

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Eldridge Bbb-b Clo Etf Etf (CLOZ)
Vanguard Index Fds Mid Cap Etf (VO)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Schwab Strategic Tr Us Tips Etf (SCHP)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)

View all positions for SRS Capital Advisors

Top funds holding Avita Therapeutics

Vanguard Group
BlackRock
Geode Capital Management
State Street Corporation
Northern Trust
Millennium Management
AQR Capital Management
Bridgeway Capital Management
Divisadero Street Capital Management
UBS Group
Goldman Sachs Group
Citadel Advisors
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Charles Schwab Investment Management
Nuveen

View all funds holding Avita Therapeutics